Kyle Dolinsky, a partner in Troutman Pepper Locke’s Health Care + Life Sciences Practice Group, was quoted in the December 27, 2024 Bloomberg Law article, “FDA’s New Guidance Plan to Face Trump’s Transparency Efforts.”

“What is up in the air with the new administration coming in is how they will interpret the standards for implementing Level 1 guidance without comment,” said Kyle A. Dolinsky, an associate at Troutman Pepper Hamilton Sanders LLP.

Insight Industries + Practices